Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Caissa Troutman, MD By comparison, non-pharmacological caloric ... Anila Chadha, MD, recommends that patients on GLP-1 agonists aim for 30 g of protein at every meal and emphasize both protein ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...

Discover the unexpected health benefits of diabetes and weight loss medications like Ozempic and Wegovy. Find out how these ...